Yantai Zhenghai Bio-Tech Co Ltd (300653) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Yantai Zhenghai Bio-Tech Co Ltd (300653) has a cash flow conversion efficiency ratio of 0.035x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥30.47 Million ≈ $4.46 Million USD) by net assets (CN¥874.47 Million ≈ $127.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300653 net asset quality index to measure how much of total assets are equity-financed.
Yantai Zhenghai Bio-Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Yantai Zhenghai Bio-Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Yantai Zhenghai Bio-Tech Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Yantai Zhenghai Bio-Tech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yantai Zhenghai Bio-Tech Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cantor Equity Partners III, Inc. Class A Ordinary Shares
NASDAQ:CAEP
|
N/A |
|
EQV Ventures Acquisition Corp.
NYSE:EQV
|
-0.003x |
|
Orion Engineered Carbons SA
NYSE:OEC
|
-0.045x |
|
Hunan Mendale Hometextile Co Ltd
SHE:002397
|
0.040x |
|
Premier Explosives Limited
NSE:PREMEXPLN
|
-0.250x |
|
Shenzhen Zqgame
SHE:300052
|
0.010x |
|
Daqian Ecology & Landscape Co Ltd
SHG:603955
|
-0.030x |
|
HaiXin Foods Co Ltd
SHE:002702
|
0.122x |
Annual Cash Flow Conversion Efficiency for Yantai Zhenghai Bio-Tech Co Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Yantai Zhenghai Bio-Tech Co Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 300653 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥888.78 Million ≈ $130.06 Million |
CN¥151.38 Million ≈ $22.15 Million |
0.170x | -10.53% |
| 2023-12-31 | CN¥948.07 Million ≈ $138.73 Million |
CN¥180.48 Million ≈ $26.41 Million |
0.190x | -12.33% |
| 2022-12-31 | CN¥865.11 Million ≈ $126.59 Million |
CN¥187.84 Million ≈ $27.49 Million |
0.217x | +2.63% |
| 2021-12-31 | CN¥785.27 Million ≈ $114.91 Million |
CN¥166.13 Million ≈ $24.31 Million |
0.212x | +15.53% |
| 2020-12-31 | CN¥646.72 Million ≈ $94.64 Million |
CN¥118.43 Million ≈ $17.33 Million |
0.183x | +4.13% |
| 2019-12-31 | CN¥588.38 Million ≈ $86.10 Million |
CN¥103.48 Million ≈ $15.14 Million |
0.176x | +20.10% |
| 2018-12-31 | CN¥529.00 Million ≈ $77.41 Million |
CN¥77.47 Million ≈ $11.34 Million |
0.146x | +8.07% |
| 2017-12-31 | CN¥483.18 Million ≈ $70.70 Million |
CN¥65.47 Million ≈ $9.58 Million |
0.136x | -37.22% |
| 2016-12-31 | CN¥228.16 Million ≈ $33.39 Million |
CN¥49.25 Million ≈ $7.21 Million |
0.216x | -15.34% |
| 2015-12-31 | CN¥179.40 Million ≈ $26.25 Million |
CN¥45.74 Million ≈ $6.69 Million |
0.255x | -47.32% |
| 2014-12-31 | CN¥63.62 Million ≈ $9.31 Million |
CN¥30.79 Million ≈ $4.51 Million |
0.484x | -58.71% |
| 2013-12-31 | CN¥29.34 Million ≈ $4.29 Million |
CN¥34.38 Million ≈ $5.03 Million |
1.172x | +133.32% |
| 2012-12-31 | CN¥-6.43 Million ≈ $-941.02K |
CN¥22.62 Million ≈ $3.31 Million |
-3.517x | -- |
About Yantai Zhenghai Bio-Tech Co Ltd
Yantai Zhenghai Biotechnology Co., Ltd. engages in the research and development, production, and sales of bioregenerative medical materials in China. The company offers oral repair membranes, absorbable dura mater patches, active biological bones, skin repair membranes, bone repair materials, surgical packing sponges, phosphoric acid etchant, dental pit and fissure sealant, light-curing composite… Read more